These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 8871758

  • 1. The role of alpha 4 integrin and intercellular adhesion molecule-1 (ICAM-1) in murine experimental autoimmune thyroiditis.
    McMurray RW, Tang H, Braley-Mullen H.
    Autoimmunity; 1996; 23(1):9-23. PubMed ID: 8871758
    [Abstract] [Full Text] [Related]

  • 2. Intrathyroidal cell phenotype in murine lymphocytic and granulomatous experimental autoimmune thyroiditis.
    McMurray RW, Sharp GC, Braley-Mullen H.
    Autoimmunity; 1994; 18(2):93-102. PubMed ID: 7537979
    [Abstract] [Full Text] [Related]

  • 3. Regulation of the induction and resolution of granulomatous experimental autoimmune thyroiditis in mice by CD8+ T cells.
    Braley-Mullen H, McMurray RW, Sharp GC, Kyriakos M.
    Cell Immunol; 1994 Feb; 153(2):492-504. PubMed ID: 8118878
    [Abstract] [Full Text] [Related]

  • 4. Differential requirement for autoantibody-producing B cells for induction of lymphocytic versus granulomatous experimental autoimmune thyroiditis.
    Braley-Mullen H, Sharp GC, Kyriakos M.
    J Immunol; 1994 Jan 01; 152(1):307-14. PubMed ID: 8254200
    [Abstract] [Full Text] [Related]

  • 5. A thyroxine-containing thyroglobulin peptide induces both lymphocytic and granulomatous forms of experimental autoimmune thyroiditis.
    Braley-Mullen H, Sharp GC.
    J Autoimmun; 1997 Dec 01; 10(6):531-40. PubMed ID: 9451592
    [Abstract] [Full Text] [Related]

  • 6. Induction of severe granulomatous experimental autoimmune thyroiditis in mice by effector cells activated in the presence of anti-interleukin 2 receptor antibody.
    Braley-Mullen H, Sharp GC, Bickel JT, Kyriakos M.
    J Exp Med; 1991 Apr 01; 173(4):899-912. PubMed ID: 1672546
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. T cell receptor V beta usage in murine experimental autoimmune thyroiditis.
    McMurray RW, Hoffman RW, Tang H, Braley-Mullen H.
    Cell Immunol; 1996 Aug 25; 172(1):1-9. PubMed ID: 8806800
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Distinctive modulation by IL-4 and IL-10 of the effector function of murine thyroglobulin-primed cells in "transfer-experimental autoimmune thyroiditis".
    Mignon-Godefroy K, Brazillet MP, Rott O, Charreire J.
    Cell Immunol; 1995 May 25; 162(2):171-7. PubMed ID: 7743543
    [Abstract] [Full Text] [Related]

  • 12. Adhesion molecules from the LFA-1/ICAM-1,3 and VLA-4/VCAM-1 pathways on T lymphocytes and vascular endothelium in Graves' and Hashimoto's thyroid glands.
    Marazuela M, Postigo AA, Acevedo A, Díaz-González F, Sanchez-Madrid F, de Landázuri MO.
    Eur J Immunol; 1994 Oct 25; 24(10):2483-90. PubMed ID: 7523142
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intravenous administration of deaggregated mouse thyroglobulin suppresses induction of experimental autoimmune thyroiditis and expression of both Th1 and Th2 cytokines.
    Tang H, Braley-Mullen H.
    Int Immunol; 1997 May 25; 9(5):679-87. PubMed ID: 9184913
    [Abstract] [Full Text] [Related]

  • 15. CD40L is necessary for the priming of effector cells for lymphocytic and granulomatous experimental autoimmune thyroiditis.
    Peterson KE, Braley-Mullen H.
    J Autoimmun; 1999 Feb 25; 12(1):1-12. PubMed ID: 10028017
    [Abstract] [Full Text] [Related]

  • 16. Expression and regulation of Fas and Fas ligand on thyrocytes and infiltrating cells during induction and resolution of granulomatous experimental autoimmune thyroiditis.
    Wei Y, Chen K, Sharp GC, Yagita H, Braley-Mullen H.
    J Immunol; 2001 Dec 01; 167(11):6678-86. PubMed ID: 11714840
    [Abstract] [Full Text] [Related]

  • 17. Suppression of autoimmune thyroid disease by FK 506: influence on thyroid-infiltrating cells, adhesion molecule expression and anti-thyroglobulin antibody production.
    Tamura K, Woo J, Murase N, Carrieri G, Nalesnik MA, Thomson AW.
    Clin Exp Immunol; 1993 Mar 01; 91(3):368-75. PubMed ID: 7680293
    [Abstract] [Full Text] [Related]

  • 18. B7.2 has opposing roles during the activation versus effector stages of experimental autoimmune thyroiditis.
    Peterson KE, Sharp GC, Tang H, Braley-Mullen H.
    J Immunol; 1999 Feb 01; 162(3):1859-67. PubMed ID: 9973452
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Synergism between mouse thyroglobulin- and vaccination-induced suppressor mechanisms in murine experimental autoimmune thyroiditis.
    Nabozny GH, Flynn JC, Kong YC.
    Cell Immunol; 1991 Sep 01; 136(2):340-8. PubMed ID: 1831404
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.